医療診断におけるAIの世界市場レポート 2025年

医療診断におけるAI市場規模は、今後数年で飛躍的な成長が見込まれます。2029年には複合年間成長率（CAGR）42.2％で109億米ドルに成長します。予測期間の成長は、免疫健康への関心の高まり、植物由来製品に対する需要の高まり、美容・化粧品産業の拡大、栄養補助食品と機能性サプリメント市場の成長、世界の持続可能性と倫理的慣行によるものと考えられます。予測期間における主な動向には、機能性食品に対する消費者の意識と需要の高まり、栄養補助食品と栄養補助食品における用途の拡大、天然と植物由来の供給源への注目、抽出と加工技術の革新、ライフスタイルとしての健康とウェルネスなどがあります。

ヘルスケアへの投資の高まりは、医療診断におけるAI市場の今後の成長を促進すると予想されます。ヘルスケア支出とは、公共部門と民間部門の両方がヘルスケアサービスに割り当てる総収入の割合を指します。この投資は、医療従事者の雇用を創出し、医療従事者の収入を増加させ、自治体の税収を押し上げ、関連商品やサービスの需要を生み出すことで、ヘルスケアにおけるAI技術の応用を支えています。例えば、カナダに本部を置く非営利団体Canadian Institute for Health Informationが2023年11月に発表したところによると、2023年の総医療支出は3,440億米ドルに達する見込みで、前年比2.8％の微増にとどまる。このように、ヘルスケアへの投資の拡大は、医療診断市場におけるAIの拡大を促進する重要な要因となっています。

テレヘルスと遠隔医療の増加は、今後数年間、医療診断におけるAI市場の成長を促進すると予想されます。遠隔医療は通信技術を利用して幅広いヘルスケアサービスや情報を遠隔地から提供するものであり、遠隔医療は特に遠隔地からの臨床診察や医療提供に焦点を当てています。AIは、遠隔患者モニタリング、バーチャル診察、デジタル画像解析を通じて、遠隔医療環境における診断効率を高める。画像解釈、病理学的分析、トリアージにおいて重要な役割を果たし、正確でタイムリーな評価を保証します。さらに、予測分析、ウェアラブルデバイスとの統合、スケーラブルなデータ管理は、AIの能力をさらに強化し、遠隔地や十分なサービスを受けていない地域におけるアクセシビリティと患者の転帰を改善します。例えば、米国を拠点とするデジタルヘルス組織であるロックヘルスが2023年2月に実施した調査によると、回答者の80％が2022年に少なくとも一度は遠隔医療を利用したことがあり、2021年の72％から増加しました。したがって、遠隔医療と遠隔医療の成長は、医療診断市場におけるAIの拡大を促す重要な要因となっています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界医療診断におけるAI PESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界の医療診断におけるAI市場：成長率分析
• 世界の医療診断におけるAI市場の実績：規模と成長, 2019-2024
• 世界の医療診断におけるAI市場の予測：規模と成長, 2024-2029, 2034F
• 世界医療診断におけるAI総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の医療診断におけるAI市場：コンポーネント別、実績と予測, 2019-2024, 2024-2029F, 2034F
• ソフトウェア
• サービス
• 世界の医療診断におけるAI市場：技術別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 自然言語処理
• コンピュータビジョン
• 機械学習
• コンテキスト認識コンピューティング
• その他のテクノロジー
• 世界の医療診断におけるAI市場専門分野別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 脳と神経
• 腫瘍学
• 心臓と血管
• 胸部と肺
• 産婦人科
• その他の専門分野
• 世界の医療診断におけるAI市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• コンピュータ支援検出
• コンピュータ支援診断
• 定量分析ツール
• 臨床的判断
• 世界の医療診断におけるAI市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院
• 診断画像センター
• 診断研究所
• その他のエンドユーザー
• 世界の医療診断におけるAI市場、ソフトウェアのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 診断画像ソフトウェア
• 病気識別ソフトウェア
• 予測分析ソフトウェア
• データ管理ソフトウェア
• 臨床意思決定支援ソフトウェア
• 世界の医療診断におけるAI市場、サービスの種類別の細分化、実績と予測, 2019-2024, 2024-2029F, 2034F
• コンサルティングサービス
• 実装サービス
• トレーニングサービス
• メンテナンスおよびサポートサービス
• マネージドサービス

第7章 地域別・国別分析

• 世界の医療診断におけるAI市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の医療診断におけるAI市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 医療診断におけるAI市場：競合情勢
• 医療診断におけるAI市場：企業プロファイル
  • Chest And Lung Overview, Products and Services, Strategy and Financial Analysis
  • Obstetrics And Gynecology Overview, Products and Services, Strategy and Financial Analysis
  • Other Specialties Overview, Products and Services, Strategy and Financial Analysis
  • International Business Machines Corporation Overview, Products and Services, Strategy and Financial Analysis
  • Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• GE HealthCare Technologies Inc.
• Digital Diagnostics Inc.
• Heartflow Inc.
• Aidoc Medical Ltd.
• Koninklijke Philips N.V.
• Nanox Imaging Ltd.
• Microsoft Corporation
• Nvidia Corporation
• Intel Corporation
• Xilinx Inc.
• Enlitic Inc.
• Aidence B.V.
• Butterfly Network Inc.
• Day Zero Diagnostics Inc.
• MicroHealth LLC

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 医療診断におけるAI市場2029：新たな機会を提供する国
• 医療診断におけるAI市場2029：新たな機会を提供するセグメント
• 医療診断におけるAI市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

AI in medical diagnostics involves the application of artificial intelligence in the field of treatment and medical diagnostics. It is employed to analyze medical imaging data, including X-rays, MRIs, ultrasounds, CT scans, and DXAs, with the aim of assisting doctors in more precise and rapid disease discovery and diagnosis.

The primary components of AI in medical diagnostics encompass software and services. The software utilized in medical diagnostics can detect various indicators, such as the abnormal proliferation of molecules in cells that may signify a disease, through image processing. Technologies involved in this process include natural language processing, computer vision, machine learning, context-aware computing, and others. These technologies find applications in specialized diagnostic cases, such as brain and neurological, oncology, cardiac and vascular, chest and lung, obstetrics and gynecology, among others. They are applied through computer-aided detection, computer-aided diagnosis, quantitative analysis tools, and clinical decision support systems, and are utilized by hospitals, diagnostic imaging centers, diagnostic laboratories, and other healthcare entities.

The AI in medical diagnostics market research report is one of a series of new reports from The Business Research Company that provides AI in medical diagnostics market statistics, including the AI in medical diagnostics industry global market size, regional shares, competitors with an AI in medical diagnostics market share, detailed AI in medical diagnostics market segments, market trends, and opportunities, and any further data you may need to thrive in the AI in medical diagnostics industry. This AI in medical diagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The AI in medical diagnostics market size has grown exponentially in recent years. It will grow from$1.92 billion in 2024 to $2.66 billion in 2025 at a compound annual growth rate (CAGR) of 38.6%. The growth in the historic period can be attributed to health consciousness, rising incidence of chronic diseases, expanding aging population, increased demand for natural products, expansion of functional foods and beverages

The AI in medical diagnostics market size is expected to see exponential growth in the next few years. It will grow to $10.9 billion in 2029 at a compound annual growth rate (CAGR) of 42.2%. The growth in the forecast period can be attributed to increasing focus on immune health, rising demand for plant-based products, expanding beauty and cosmetics industry, nutraceuticals and functional supplements market growth, global sustainable and ethical practices. Major trends in the forecast period include rising consumer awareness and demand for functional foods, expanding applications in nutraceuticals and dietary supplements, focus on natural and plant-based sources, innovations in extraction and processing technologies, health and wellness as a lifestyle.

The rising investment in healthcare is anticipated to drive the growth of the AI market in medical diagnostics in the future. Health expenditure refers to the share of total revenue allocated by both public and private sectors for healthcare services. This investment creates jobs for healthcare professionals, increases earnings for healthcare workers, boosts municipal tax revenues, and generates demand for related goods and services, thereby supporting the application of AI technology in healthcare. For example, the Canadian Institute for Health Information, a non-profit organization based in Canada, reported in November 2023 that total health expenditure is expected to reach $344 billion in 2023, marking a modest increase of 2.8% from the previous year. Thus, the growing investment in healthcare is a key factor driving the expansion of AI in the medical diagnostics market.

The rise in telehealth and telemedicine is expected to drive the growth of the AI market in medical diagnostics in the coming years. Telehealth involves using telecommunications technology to deliver a broad range of healthcare services and information remotely, while telemedicine focuses specifically on remote clinical consultations and healthcare delivery. AI enhances diagnostic efficiency in telehealth environments through remote patient monitoring, virtual consultations, and digital imaging analysis. It plays a crucial role in image interpretation, pathology analysis, and triage, ensuring accurate and timely assessments. Additionally, predictive analytics, integration with wearable devices, and scalable data management further strengthen AI capabilities, improving accessibility and patient outcomes in remote or underserved areas. For instance, a survey conducted by Rock Health, a U.S.-based digital health organization, in February 2023 revealed that 80% of respondents had used telemedicine at least once in 2022, up from 72% in 2021. Therefore, the growth of telehealth and telemedicine is a significant factor driving the expansion of AI in the medical diagnostics market.

The AI in medical diagnostics market is witnessing a significant trend characterized by product innovations, with major companies actively introducing new solutions to maintain their market positions. In March 2023, Qritive, a Singapore-based software company, launched the 'Qai Prostate,' an AI-powered tool specifically designed for prostate cancer diagnosis. This innovative product is capable of distinguishing between benign and malignant tumors, precisely identifying the locations of prostatic cancer, and identifying prostatic adenocarcinoma. Notably, the Qai Prostate tool enhances laboratory productivity by allowing pathologists to select, prioritize, and focus on cases that are most beneficial to them.

Major companies in the AI in medical diagnostics market are strategically developing medical imaging suites to gain a competitive advantage. Medical imaging involves techniques and processes that create visual representations of the interior of the body for clinical analysis and medical intervention. In October 2022, Google LLC, a US-based technology company, introduced the Medical Imaging Suite, an industry solution aimed at improving accessibility, interoperability, and usability of healthcare imaging data. The suite leverages AI for imaging to support faster and more accurate diagnosis, enhance productivity for healthcare workers, and improve patient care outcomes. It includes AI-assisted annotation tools, advanced analytics through tools such as BigQuery and Looker, accelerated AI pipeline development with Vertex AI, and flexible deployment options for cloud, on-premises, or edge settings. This comprehensive and adaptable solution addresses the evolving needs of healthcare organizations.

In October 2024, GE HealthCare Technologies Inc., a medical technology company based in the U.S., acquired Intelligent Ultrasound Group PLC for around $53 million. This acquisition allows GE HealthCare to incorporate Intelligent Ultrasound's AI-driven tools into its ultrasound offerings, aiming to improve workflow efficiency, minimize repetitive tasks, and simplify ultrasound examinations for clinicians. Intelligent Ultrasound Group PLC, a diagnostics company located in the UK, focuses on AI-driven ultrasound software and training tools for medical diagnostics.

Major companies operating in the AI in medical diagnostics market include International Business Machines Corporation, Siemens Healthineers AG, GE HealthCare Technologies Inc., Digital Diagnostics Inc., Heartflow Inc., Aidoc Medical Ltd., Koninklijke Philips N.V., Nanox Imaging Ltd., Microsoft Corporation, Nvidia Corporation, Intel Corporation, Xilinx Inc., Enlitic Inc., Aidence B.V., Butterfly Network Inc., Day Zero Diagnostics Inc., MicroHealth LLC, Arterys Inc., PathAI Inc., Zebra Medical Vision Inc., Tempus Labs Inc., Caption Health Inc., Proscia Inc., AliveCor Corporation, ResApp Health Limited, Volpara Health Technologies Limited, Koios Medical Inc., Ultromics Limited, MaxQ AI Ltd., Paige.AI Inc.

North America was the largest region in the AI in medical diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the global AI in medical diagnostics market report during the forecast period. The regions covered in the ai in medical diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the ai in medical diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The AI in medical diagnostics market consists of revenues earned by entities by providing services such as magnetic resonance imaging (MRI), ultrasound, and computed tomography scans, robotic process automation, machine learning, natural language processing, and rule-based expert systems. The market value includes the value of related goods sold by the service provider or included within the service offering. AI in the medical diagnostics market also includes sales of dental devices, diabetes care devices, nephrology and urology devices, neurology devices, and physical robots which are used in providing AI in medical diagnostics services. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

AI In Medical Diagnostics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on ai in medical diagnostics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for ai in medical diagnostics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The ai in medical diagnostics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Component: Software; Services
• 2) By Technology: Natural Language Processing; Computer Vision; Machine Learning; Context-Aware Computing; Other Technologies
• 3) By Specialty: Brain And Neurological; Oncology; Cardiac And Vascular; Chest And Lung; Obstetrics And Gynecology; Other Specialties
• 4) By Application: Computer-Aided Detection; Computer-Aided Diagnosis; Quantitative Analysis Tools; Clinical Decision
• 5) By End User: Hospitals; Diagnostics Imaging Centers; Diagnostics Laboratories; Other End Users
• Subsegments:
• 1) By Software: Diagnostic Imaging Software; Disease Identification Software; Predictive Analytics Software; Data Management Software; Clinical Decision Support Software
• 2) By Services: Consulting Services; Implementation Services; Training Services; Maintenance And Support Services; Managed Services
• Companies Mentioned: International Business Machines Corporation; Siemens Healthineers AG; GE HealthCare Technologies Inc.; Digital Diagnostics Inc.; Heartflow Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. AI In Medical Diagnostics Market Characteristics

3. AI In Medical Diagnostics Market Trends And Strategies

4. AI In Medical Diagnostics Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market

5. Global AI In Medical Diagnostics Growth Analysis And Strategic Analysis Framework

• 5.1. Global AI In Medical Diagnostics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global AI In Medical Diagnostics Market Growth Rate Analysis
• 5.4. Global AI In Medical Diagnostics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global AI In Medical Diagnostics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global AI In Medical Diagnostics Total Addressable Market (TAM)

6. AI In Medical Diagnostics Market Segmentation

• 6.1. Global AI In Medical Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Software
• Services
• 6.2. Global AI In Medical Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Natural Language Processing
• Computer Vision
• Machine Learning
• Context-Aware Computing
• Other Technologies
• 6.3. Global AI In Medical Diagnostics Market, Segmentation By Specialty, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Brain And Neurological
• Oncology
• Cardiac And Vascular
• Chest And Lung
• Obstetrics And Gynecology
• Other Specialties
• 6.4. Global AI In Medical Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Computer-Aided Detection
• Computer-Aided Diagnosis
• Quantitative Analysis Tools
• Clinical Decision
• 6.5. Global AI In Medical Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Diagnostics Imaging Centers
• Diagnostics Laboratories
• Other End Users
• 6.6. Global AI In Medical Diagnostics Market, Sub-Segmentation Of Software, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Diagnostic Imaging Software
• Disease Identification Software
• Predictive Analytics Software
• Data Management Software
• Clinical Decision Support Software
• 6.7. Global AI In Medical Diagnostics Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Consulting Services
• Implementation Services
• Training Services
• Maintenance And Support Services
• Managed Services

7. AI In Medical Diagnostics Market Regional And Country Analysis

• 7.1. Global AI In Medical Diagnostics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global AI In Medical Diagnostics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific AI In Medical Diagnostics Market

• 8.1. Asia-Pacific AI In Medical Diagnostics Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific AI In Medical Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific AI In Medical Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific AI In Medical Diagnostics Market, Segmentation By Specialty, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China AI In Medical Diagnostics Market

• 9.1. China AI In Medical Diagnostics Market Overview
• 9.2. China AI In Medical Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China AI In Medical Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China AI In Medical Diagnostics Market, Segmentation By Specialty, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India AI In Medical Diagnostics Market

• 10.1. India AI In Medical Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India AI In Medical Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India AI In Medical Diagnostics Market, Segmentation By Specialty, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan AI In Medical Diagnostics Market

• 11.1. Japan AI In Medical Diagnostics Market Overview
• 11.2. Japan AI In Medical Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan AI In Medical Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan AI In Medical Diagnostics Market, Segmentation By Specialty, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia AI In Medical Diagnostics Market

• 12.1. Australia AI In Medical Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia AI In Medical Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia AI In Medical Diagnostics Market, Segmentation By Specialty, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia AI In Medical Diagnostics Market

• 13.1. Indonesia AI In Medical Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia AI In Medical Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia AI In Medical Diagnostics Market, Segmentation By Specialty, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea AI In Medical Diagnostics Market

• 14.1. South Korea AI In Medical Diagnostics Market Overview
• 14.2. South Korea AI In Medical Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea AI In Medical Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea AI In Medical Diagnostics Market, Segmentation By Specialty, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe AI In Medical Diagnostics Market

• 15.1. Western Europe AI In Medical Diagnostics Market Overview
• 15.2. Western Europe AI In Medical Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe AI In Medical Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe AI In Medical Diagnostics Market, Segmentation By Specialty, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK AI In Medical Diagnostics Market

• 16.1. UK AI In Medical Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK AI In Medical Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK AI In Medical Diagnostics Market, Segmentation By Specialty, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany AI In Medical Diagnostics Market

• 17.1. Germany AI In Medical Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany AI In Medical Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany AI In Medical Diagnostics Market, Segmentation By Specialty, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France AI In Medical Diagnostics Market

• 18.1. France AI In Medical Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France AI In Medical Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France AI In Medical Diagnostics Market, Segmentation By Specialty, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy AI In Medical Diagnostics Market

• 19.1. Italy AI In Medical Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy AI In Medical Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy AI In Medical Diagnostics Market, Segmentation By Specialty, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain AI In Medical Diagnostics Market

• 20.1. Spain AI In Medical Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain AI In Medical Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain AI In Medical Diagnostics Market, Segmentation By Specialty, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe AI In Medical Diagnostics Market

• 21.1. Eastern Europe AI In Medical Diagnostics Market Overview
• 21.2. Eastern Europe AI In Medical Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe AI In Medical Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe AI In Medical Diagnostics Market, Segmentation By Specialty, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia AI In Medical Diagnostics Market

• 22.1. Russia AI In Medical Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia AI In Medical Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia AI In Medical Diagnostics Market, Segmentation By Specialty, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America AI In Medical Diagnostics Market

• 23.1. North America AI In Medical Diagnostics Market Overview
• 23.2. North America AI In Medical Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America AI In Medical Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America AI In Medical Diagnostics Market, Segmentation By Specialty, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA AI In Medical Diagnostics Market

• 24.1. USA AI In Medical Diagnostics Market Overview
• 24.2. USA AI In Medical Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA AI In Medical Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA AI In Medical Diagnostics Market, Segmentation By Specialty, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada AI In Medical Diagnostics Market

• 25.1. Canada AI In Medical Diagnostics Market Overview
• 25.2. Canada AI In Medical Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada AI In Medical Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada AI In Medical Diagnostics Market, Segmentation By Specialty, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America AI In Medical Diagnostics Market

• 26.1. South America AI In Medical Diagnostics Market Overview
• 26.2. South America AI In Medical Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America AI In Medical Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America AI In Medical Diagnostics Market, Segmentation By Specialty, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil AI In Medical Diagnostics Market

• 27.1. Brazil AI In Medical Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil AI In Medical Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil AI In Medical Diagnostics Market, Segmentation By Specialty, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East AI In Medical Diagnostics Market

• 28.1. Middle East AI In Medical Diagnostics Market Overview
• 28.2. Middle East AI In Medical Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East AI In Medical Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East AI In Medical Diagnostics Market, Segmentation By Specialty, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa AI In Medical Diagnostics Market

• 29.1. Africa AI In Medical Diagnostics Market Overview
• 29.2. Africa AI In Medical Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa AI In Medical Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa AI In Medical Diagnostics Market, Segmentation By Specialty, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. AI In Medical Diagnostics Market Competitive Landscape And Company Profiles

• 30.1. AI In Medical Diagnostics Market Competitive Landscape
• 30.2. AI In Medical Diagnostics Market Company Profiles
  • 30.2.1. Chest And Lung Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Obstetrics And Gynecology Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Other Specialties Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. International Business Machines Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis

31. AI In Medical Diagnostics Market Other Major And Innovative Companies

• 31.1. GE HealthCare Technologies Inc.
• 31.2. Digital Diagnostics Inc.
• 31.3. Heartflow Inc.
• 31.4. Aidoc Medical Ltd.
• 31.5. Koninklijke Philips N.V.
• 31.6. Nanox Imaging Ltd.
• 31.7. Microsoft Corporation
• 31.8. Nvidia Corporation
• 31.9. Intel Corporation
• 31.10. Xilinx Inc.
• 31.11. Enlitic Inc.
• 31.12. Aidence B.V.
• 31.13. Butterfly Network Inc.
• 31.14. Day Zero Diagnostics Inc.
• 31.15. MicroHealth LLC

32. Global AI In Medical Diagnostics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The AI In Medical Diagnostics Market

34. Recent Developments In The AI In Medical Diagnostics Market

35. AI In Medical Diagnostics Market High Potential Countries, Segments and Strategies

• 35.1 AI In Medical Diagnostics Market In 2029 - Countries Offering Most New Opportunities
• 35.2 AI In Medical Diagnostics Market In 2029 - Segments Offering Most New Opportunities
• 35.3 AI In Medical Diagnostics Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer